Position in ENLV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$40,649
-$87,995 QoQ
Shares Held
4,927
-46.6% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 25 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENLV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. ENLV ranks #401 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in ENLV
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,649 | 73,909 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $128,644 | 138,328 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $24,596 | 34,988 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $4,201 | 4,040 | Shares | Defined | 2025-11-13 | |
| 2025-03-31 | $15 | 16 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $18 | 16 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,403 | 3,217 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $22 | 16 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $11,631 | 3,069 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $9,890 | 3,663 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,090 | 690 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $46,785 | 17,810 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $114,488 | 31,453 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $131,705 | 33,445 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $135,451 | 31,871 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $83,081 | 18,381 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $98,847 | 17,683 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $135,286 | 21,646 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $152,684 | 15,454 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $119,438 | 13,420 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $120,569 | 10,872 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $188,823 | 22,399 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $60,766 | 10,230 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,740 | 344 | Shares | Sole | 2020-07-31 | |
| No filing history on record for this holder in this stock. | ||||||